Full Length Research Paper
References
|
Abubakar UF, Adam R, Muhktar MM, Muhammad A, Yahuza AA, Ibrahim SS (2020). Identification of mutations in antimalarial resistance gene Kelch13 from Plasmodium falciparum isolates in Kano, Nigeria. Tropical Medicine and Infectious Disease 5(2):85. |
|
|
Ajogbasile FV, Oluniyi PE, Kayode AT, Akano KO, Adegboyega BB, Philip C, Ogbulafor N, Okafor HU, Oguche S, Wammanda RD, Mokuolu OA, Folarin OA, Happi CT (2022). Molecular profiling of the artemisinin resistance Kelch 13 gene in Plasmodium falciparum from Nigeria. Public Library of Science One 17(2):e0264548. |
|
|
Aju-Ameh C, Awolola S, Mwansat G, Mafuyai H (2017). Prevalence of asymptomatic malaria in selected communities in Benue state, North central Nigeria: a silent threat to the national elimination goal. Edorium Journal of Epidemiology 3:1-7.24. |
|
|
Arrow KJ, Panosian C, Gelband H (eds). (2004). Saving lives, buying time: economics of malaria drugs in an age of resistance. National Academic Press. |
|
|
Arya A, Foko LPK, Chaudry C, Sharma A, Singh V (2021). Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions- India and sub-Saharan Africa. International Journal for Parasitology: Drugs and Drug Resistance 15:43-56. |
|
|
Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C (2014). Spread of artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine 371(5):411-423. |
|
|
Awosolu OB, Yahaya ZS, Farah Haziqah MT, Simon-Oke IA, Fakunle C (2021). A cross-sectional study of the prevalence, density, and risk factors associated with malaria transmission in urban communities of Ibadan, Southwestern Nigeria. Heliyon 7(1):e05975. |
|
|
Benjamin GY, Inabo HI, Muhammad HID, Olayinka BO (2020). Genetic markers associated with antimalarial drug resistance and haemoglobin genotypes among patients in Kaduna state, Nigeria. Nigerian Journal of Microbiology 35(1):5568-5575. |
|
|
Blasco B, Leroy D, Fidock DA (2017). Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nature Medicine 23(8):917-928. |
|
|
Chollom TD, Ofodile N, Ubadike O. Application Techniques of Multi-objective particle swarm optimization: Aircraft flight control. In2016 UKACC 11th International Conference on Control (CONTROL) 2016 Aug 31 (pp. 1-6). IEEE |
|
|
Dabaro D, Birhanu Z, Negash A, Hawaria D, Yewhalaw D (2021). Effects of rainfall, temperature, and topography on malaria incidence in elimination targeted districts of Ethiopia. Malaria Journal 20(1):104. |
|
|
Foley M, Tilley L (1997). Quinoline antimalarials: mechanisms of action and resistance. International Journal for Parasitology 27:231-240. |
|
|
Gething PW, Casey DC, Weiss DJ, Bisanzio D, Bhatt S, Cameron E, Battle, KE, Dalrymple U, Rozier J, Rao PC, Kutz MJ, Barber RM, Huynh C, Shackelford KA, Coates MM, Nguyen G, Fraser MS, Kulikoff R, Wang H, Naghavi M, Smith DL, Murray CJL, Hay SI, Lim SS (2016). Mapping Plasmodium falciparum mortality in Africa between 1990 and 2015. New England Journal of Medicine 375:2435-2445. |
|
|
Ikegbunam M, Ojo JA, Kokou K, Morikwe U, Nworu C, Uba C, Esimone C, Velavan TP, Ojurongbe O (2021). Absence of Plasmodium falciparum artemisinin resistance gene mutations eleven years after the adoption of artemisinin-based combination therapy in Nigeria. Malaria Journal 20:434. |
|
|
Issa I, Lamine MM, Hubert V, Ilagouma A, Adehossi E, Mahamadou A, Lobo NF, Sarr D, Shollenberger LM, Sandrine H, Jambou R, Laminou IM (2022). Prevalence of mutations in the Pfdhfr, Pfdhps, and Pfmdr1 genes of malarial parasites isolated from symptomatic patients in Dogondoutchi, Niger. Tropical Medicine and Infectious Diseases 7(8):155. |
|
|
Kaur H, Clarke S, Lalani M, Phanouvong S, Guérin P, McLoughlin A, Wilson BK, Deats M, Plançon A, Hopkins H, Miranda D, Schellenberg D (2016). Fake anti-malarials: Start with the facts. Malaria Journal 15 p. |
|
|
Mafuyai HB, Tanko I, Oguche S, Egah D, Envuladu EA, Mwansat GS, Pam DD, Shwe D, Nannvyat N, Oguche D, Barshep Y (2022). Malaria case presentation: The results of a web based malaria surveillance in Plateau State, Nigeria. International Journal of Medical Evaluation and Physical 6(1):13-19. |
|
|
Nanvyat N, Mulambalah C, Barshep Y, Ajiji J, Dakul DA, Tsingalia MH (2018). Malaria transmission trends and its lagged association with climatic factors in the highlands of Plateau State, Nigeria. Tropical Parasitology 8(1). |
|
|
Nanvyat N, Mulambalah C, Barshep Y, Tsingalia MH, Dakul D(2017a). Retrospective analysis of malaria transmission patterns and its association with meteorological variables in lowland areas of Plateau state, Nigeria. International Journal of Mosquito Research 4(4):101-106. |
|
|
Nanvyat N, Mulambalah CS, Ajiji JA, Dakul DA, Tsingalia MH (2017b). Prevalence of Human Malaria Infection and its transmission pattern in the highlands and lowlands of Plateau State, Nigeria. Indian Journal of Sciences and Technology 10(32). |
|
|
Okoli C, Solomon M (2014). Prevalence of hospital-based malaria among children in Jos, North-central Nigeria. British Journal of Medicine and Medical Research 4(17):3231-3237. |
|
|
Ouji M, Augereau M, Paloque L, Benoit-Vical F (2018). Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination. Parasite 25 p. |
|
|
Packard RM (2014). The origins of antimalarial-drug resistance. New England Journal of Medicine 371(5):397-399. |
|
|
Pam DD, Neslea AM, Lapang M, Njila HL, Ombugadu A, Akindigh TM (2019). Human nighttime outdoor activities in a rural community of North-central Nigeria: Implications for residual malaria transmission. International Journal of Mosquito Research 6(4):26-30. |
|
|
Reddy MC, Rineetha T, Sreeharshika D, Jothula KY (2020). Health care seeking behaviour among rural women in Telangana: A cross sectional study. Journal of Family Medicine and Primary Care 9(9):4778-4783. |
|
|
Tse EG, Korsik M, Todd MH (2019). The past, present and future of antimalarial medicines. Malaria Journal 18(1):1-21. |
|
|
Tuedom AG, Sarah-Matio EM, Moukoko CE, Feufack-Donfack BL, Maffo CN, Bayibeki AN, Awono-Ambene HP, Ayong L, Berry A, Abate L, Morlais I (2021). Antimalarial drug resistance in Central and Adamawa regions of Cameroon: Prevalence of mutations in P. falciparum crt, Pfmdr1, Pfdhfr and Pfdhps genes. PLoS One 16(8):e0256343. |
|
|
White NJ (1999). Antimalarial drug resistance and combination chemotherapy. Philosophical Transactions of the Royal Society B: Biological Science 354(1384):739-749. |
|
|
World Health Organization (WHO) (2020). World Malaria Report. WHO Geneva. |
|
|
World Health Organization (WHO) (2018a). World Malaria Report. WHO Geneva. |
|
|
World Health Organization (WHO) (2018b). Artemisinin resistance and artemisinin-based combination therapy efficacy. Status Report Global Malaria Programme. WHO Geneva. |
|
|
Zhao L, Pi L, Qin Y, Lu Y, Zeng W, Xiang Z, Qin P, Chen X, Li C, Zhang Y, Wang S, Si Y, Yang G, Rosenthal BM, Huang Y, Yang Z (2020). Widespread resistance mutations to sulfadoxine-pyrimethamine in malaria parasites imported to China from Central and Western Africa. International Journal for parasitology. Drugs and Drug Resistance 12:1-6. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
